Pelthos Therapeutics Inc. (PTHS)
NYSE: PTHSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
Market open · Delayed 15 min · as of Oct 7, 4:00 PM ET
PTHS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $80.36M
- EPS (TTM)
- -$27.53
- Dividend yield
- None
- 52-week range
- 18.19 – 37.50
- Day range
- 20.99 – 21.99
- Volume / Avg
- 111 / 59.15K
- Beta
- —
- Shares outstanding
- 3.83M
52-week range
PTHS stock today
Shares of Pelthos Therapeutics (PTHS) are trading lower on Oct 7 at $20.99, a drop of 2.28% or $0.49 per share, versus the S&P 500's 0.37% decline. Shares are 44.0% below their 52-week high of $37.50, set on Nov 6, 2025 and 15.4% above the 52-week low of $18.19, near the bottom of the past year's range. PTHS is down 32.3% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 24.5%.
Pelthos Therapeutics has posted a net loss over the last twelve months (EPS of -$27.53), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Pelthos Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year
- 2024
Pelthos Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CRDFCardiff Oncology Inc. | 1.07 | -2.29% | $82.85M | vs PTHS |
| GRMLGreenland Mines Ltd. | 5.80 | -0.60% | $77.35M | vs PTHS |
| OKYOOKYO Pharma Limited | 1.46 | +2.17% | $76.62M | vs PTHS |
| NMRANeumora Therapeutics Inc. | 0.451 | -3.69% | $84.74M | vs PTHS |
| CGTXCognition Therapeutics Inc. | 0.9439 | +0.78% | $89.76M | vs PTHS |
| CSBRChampions Oncology Inc. | 4.88 | -2.59% | $67.92M | vs PTHS |
| ATRAAtara Biotherapeutics Inc. | 9.42 | +0.53% | $94.56M | vs PTHS |
| CRBUCaribou Biosciences Inc. | 0.5824 | -5.67% | $62.44M | vs PTHS |
Indexes, lists and sector
Pelthos Therapeutics stock FAQ
What is Pelthos Therapeutics's stock price today?
PTHS last traded at $20.99 as of Oct 7, 4:00 PM EDT, down 2.28% on the day. Prices are delayed at least 15 minutes.
Does Pelthos Therapeutics pay a dividend?
No. Pelthos Therapeutics does not currently pay a regular cash dividend.
Has PTHS ever split its stock?
Yes. The most recent PTHS stock split was a 1-for-10 split on Jul 2, 2025.
What is the PTHS 52-week high?
The 52-week high for PTHS is $37.50 and the 52-week low is $18.19. The stock is currently 44.0% below its high.